Future Meetings 2014


The Henry M. and Lillian Stratton

Basic Research Single Topic Conference

Non-coding RNAs in Liver Function and Dysfunction

March 7 – 8

InterContinental Miami

Miami, Florida

AASLD activity at American College of Physicians (ACP)

Evaluation of the Patient with Abnormal Liver Tests

April

ACP Annual Meeting

Orlando, Florida

Digestive Disease Week® (DDW)

May 3 – 6

McCormick Place Convention Center

Chicago, Illinois

Emerging Trends Conference

Antifibrotic Drug Trials: Strategies and Endpoints

June 21 – 22

Westin Chicago River North

Chicago, Illinois

ASGE/AASLD co-sponsored activity

Endoscopy in the Patient with Liver Disease: Radiologists, Hepatologists and Endoscopists

June 22 – 23

ASGE Conference Center

Chicago, Illinois

AASLD/EASL

Special Conference on Hepatitis C

September 12 – 13

Sheraton-New York Times Square

New York, New York

Postgraduate Course

Inflammation and Immunity in Acute and Chronic Liver Diseases

November 7 – 8

Hynes Convention Center

Boston, Massachusetts

The Liver Meeting®

November 7 – 11

Hynes Convention Center

Boston, Massachusetts

Meeting-at-a-Glance2A
General Meeting Information5A
Limited License7A
Disclosure Index8A
Oral Sessions
Friday, November 136A
Saturday, November 243A
Sunday, November 347A
Monday, November 467A
Tuesday, November 585A
Poster Sessions
Saturday, November 292A
Sunday, November 3119A
Monday, November 4149A
Tuesday, November 5177A

The Scientific Program Committee has created an exciting and diverse scientific program that highlights new technology, current clinical issues and hot topics facing the hepatology community. Members include:

J. Gregory Fitz, MD, Co-Chair

Gary L. Davis, MD, Co-Chair

Kenneth D. Chavin, MD, PhD

Mark J. Czaja, MD

Adrian M. Di Bisceglie, MD, FACP

Marc G. Ghany, MD

Mary E. Rinella, MD

Ronald J. Sokol, MD

Gyongyi Szabo, MD, PhD

Rebecca T. Wells, MD

Accreditation and CME Information

The overall goal of The Liver Meeting® is to provide a forum for the exchange of groundbreaking research and clinical information in diseases of the liver and biliary tract and in liver transplantation.

Intended Audience

The Liver Meeting® 2013 is designed for physicians, surgeons, scientists, educators, nurses, physician assistants, and all other hepatology health professionals.

AASLD takes responsibility for the content, quality, and scientific integrity of this CME activity.

Learning Objectives

  • Provide a forum for exchange of groundbreaking basic and clinical research in liver disease
  • Create an arena for the presentation and interchange of opinions on state-of-the-art care and management of the full spectrum of patients with liver disease

Accreditation Statement

The American Association for the Study of Liver Diseases (AASLD) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

AASLD designates these live activities for AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Maximum Credits Available

Annual Meeting (State-of-the-Art Lectures; President's Choice; General Hepatology Update; Advances for Practitioners; Plenaries and Parallel Sessions; Global Forum; Federal Focus;

and Emerging Trends) 18. 0 CME Credits

Postgraduate Course 12. 0 CME Credits/***11. 75 Contact Hours

Basic Research Workshop4. 0 CME Credits

AASLD/IASL Program*4. 0 CME Credits

Hepatology Associates Course5. 5 CME Credits/***5. 0 Contact Hours

AASLD/ILTS Transplant Course* 7. 5 CME Credits/***6. 0 Contact Hours

AASLD/NASPGHAN

Pediatric Symposium** 3. 0 CME Credits

AASLD/ASGE Endoscopy Course** 6. 5 CME Credits

Maintenance of Certification 2. 0 CME Credits

*These activities have been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the American Association for the Study of Liver Diseases (AASLD), and the International Liver Transplantation Society (ILTS) and the International Association for the Study of the Liver (IASL). AASLD is accredited by the ACCME to provide continuing medical education for physicians.

**Co-sponsored activity: The American Association for the Study of Liver Diseases (AASLD) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

***The Institute for Advancement of Human Behavior (IAHB) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This course is co-provided by IAHB and AASLD.

Only the following sessions will award nurse continuing education contact hours as noted:

AASLD/ILTS Transplant Course - 6. 0 contact hours

Postgraduate Course - 11. 75 contact hours

Hepatology Associates Course - 5. 00 contact hours

Please note: CME will not be provided for all sessions at The Liver Meeting® 2013. ACCME guidelines prohibit CME providers from offering credit for programs that include presentations by employees of commercial interest that relate to the business lines and products of its employer. Sessions offered for credit, and the amount of credit available for each, are listed above.

Faculty Disclosure

It is the policy of the AASLD to ensure balance, independence, objectivity, and scientific rigor in all its individually or jointly sponsored educational programs.

All faculty/authors participating in any AASLD sponsored programs, as well as planners and committee members are expected to disclose any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing medical education program.

When an unlabeled use of a commercial product, or an investigational use not yet approved for any purpose is discussed during an educational activity, the speaker shall disclose to the audience that the product is not labeled for the use under discussion or that the product is still investigational.

All disclosure information is provided to the activity participant prior to the start of the educational activity. In addition, disclosure slides will be the first slide in each oral presentation viewed by participants. AASLD will identify and resolve all conflicts of interest prior to program implementation.

Disclaimer Statement

Statements, opinions, and results of studies presented at The Liver Meeting® are solely those of the authors and do not reflect the policy or position of AASLD. AASLD does not provide any warranty to the accuracy or reliability of information presented either verbally or in writing by presenters. No responsibility is assumed by AASLD for any injury and/or damage to persons or property resulting from any use of such information.

Use of AASLD Scientific Program Content

Information presented during The Liver Meeting® is the property of AASLD and the presenter. Information may not be recorded, photographed, copied, photocopied, transferred to electronic format, reproduced, or distributed without the written permission of AASLD and the presenter Any use of the program content,which includes,but it is not limited to oral presentations,audio visual materials used by speakers,and program handouts,without the written consent of AASLD is prohibited.

Activity Evaluation and CME Certificate/Certificate of Attendance

Complete the overall Annual Meeting Evaluation and receive your CME certificate or Certificate of Attendance online. You may access the online system at Tech Connect in the Walter E.

Washington Convention Center, as well as from your personal or office computer via the AASLD website, www.aasld.org, during and after the meeting concludes. Please complete the overall evaluation and print your certificate by the end of March 2014.

CE Evaluation

The CE Evaluation site will be accessible via up to one month after the conclusion of the meeting.

Outcomes Follow-up Survey

An outcomes survey will be sent to all attendees within three months post activity to assist AASLD in determining what impact these activities have had on the attendee's practice.

Ancillary